Back to search results

Yogic Breathing and Meditation for Spinal Cord Disorders

This study is looking at how well yogic breathing and meditation can help people with spinal cord disorders. Researchers want to see if these practices improve breathing, fatigue, emotional well-being, and overall quality of life. You might be able to join if you are an adult aged 18 to 89 with a spinal cord disorder, live in the community, can follow simple instructions, and have internet access for virtual sessions. The main goal is to see if depressive symptoms improve after 8 and 16 weeks. This study plans to include 30 participants, but its current status is unclear.

Study design
This is an interventional study planning to enroll 30 participants to test yogic breathing and meditation.
What's involved
You would complete questionnaires three times, participate in two 30-minute virtual yogic breathing and meditation sessions per week for 8 weeks, and have one interview, for a total study duration of 2 months.
Compensation
Not stated in the trial record.
Follow-up
You will be followed for depressive symptoms at 8 and 16 weeks after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07655531

Yogic Breathing Exercise and Meditation for People With Spinal Cord Disorders

Recruiting
NAAges 18–89Interventional
University of Alabama at Birmingham
~30 participants
Updated 2026-07-23 on ClinicalTrials.gov
What's tested:yogic breathing and meditation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Depressive symptoms as assessed by the PHQ-9
Measured over change from baseline in depressive symptoms at 8 and 16 weeks
+1 more outcome measured

Conditions

Spinal Cord Disorders

Explore related trials

Spinal Cord Disorder

Where it's being run

1 sites across 1 states
Alabama1

Study leadership

  • Hon Yuen, PhD · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham

Who to contact

Hon Yuen, PhD
[email protected]
12059346301
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

spinal cord disorders
community-dwelling adults aged ≥ 18 years
able to follow simple, three-step verbal instructions (e.g., close your eyes, open your mouth, close your mouth)
access to the internet and an electronic device with videoconferencing capability
able to set up virtual sessions with/without caregiver assistance
sufficient English language proficiency to provide consent for study participation and complete self-report questionnaires

Exclusion

suicidal intent requiring emergency care
bedridden with continuous use of noninvasive ventilation
participating in weekly pulmonary PT, psychological therapy, or a clinical trial that could affect proposed study outcomes.

What this trial measures

  • Depressive symptoms as assessed by the PHQ-9change from baseline in depressive symptoms at 8 and 16 weeks

    The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm. Each question is scored from 0 to 3, with a maximum total score of 27. Higher scores indicate more severe depressive symptomology.

  • Patient health questionnaire (PHQ-9)baseline, post-program (8th week), and 16th week

    The Patient Health Questionnaire-9 (PHQ-9) consists of nine questions inquiring about symptoms experienced over the past two weeks, ranging from low energy and sleep issues to feelings of hopelessness and self-harm. Each question is scored from 0 to 3, with a maximum total score of 27. Higher scores indicate more severe depressive symptomology.